GSK's two-drug HIV treatment meets main goal in late stage studies

(Reuters) - GlaxoSmithKline said on Thursday that its two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies.

from Reuters: Health News https://ift.tt/2sXeFRT